Investec Bank plc has filed a public dealing disclosure under Rule 8.5 of the Takeover Code relating to Advanced Medical Solutions Group plc (AMS.L).
The disclosure identifies Investec as an exempt principal trader acting in a client-serving capacity with recognised intermediary status under the Code.
Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group plc, establishing its connection to the party named in the filing.
The dealings were undertaken on 24th June 2026, with the formal disclosure published the following day on 25th June 2026.
In terms of purchase activity, Investec Bank executed purchases of 1,053,512 ordinary shares in Advanced Medical Solutions Group during the dealing period.
The highest price paid per unit on purchases reached 241 pence, while the lowest price paid came in at 239 pence per ordinary share.
On the sales side, Investec Bank recorded disposals totalling 1,052,012 ordinary shares within the same dealing session.
Sales were executed at prices ranging between 239 pence and 241 pence per unit, closely mirroring the purchase price range recorded on the same date.
The filing confirms that no cash-settled derivative transactions, stock-settled derivative transactions, or other dealings such as subscriptions or conversions were recorded during this period.
Investec also confirmed there are no indemnity arrangements, option agreements, or understandings relating to voting rights or future acquisition and disposal of relevant securities connected to this disclosure.
The contact named in the filing is Priyali Bhattacharjee, reachable by telephone for any inquiries relating to the disclosure.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service, ensuring full market transparency during offer periods.
